Market Cap (In KRW)
974.73 Billion
Revenue (In KRW)
143.02 Billion
Net Income (In KRW)
24.8 Billion
Avg. Volume
374.02 Thousand
- Currency
- KRW
- Country
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 7390.0-13800.0
- PE
- -
- EPS
- -
- Beta Value
- 0.445
- ISIN
- KR7287410005
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Industry
- CEO
- Won-Ju Lee
- Employee Count
- -
- Website
- https://www.jeisys.com/2016
- Ipo Date
- 2021-03-19
- Details
- Jeisys Medical Inc. designs, develops, and manufactures medical device for plastic surgeons, dermatologist, physicians, and healthcare professionals in South Korea and internationally. The company offers products for treatment areas, such as skin rejuvenation, lifting/tightening, pigmentation treatments, fat reduction, acne, tattoo removal, and scars and striae distensae under the ULTRAcel Q+ system, Cellec V system, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel brands. It provides its products through a network of distributors. The company was founded in 2001 and is based in Seoul, South Korea.
More Stocks
-
NSPRInspireMD, Inc.
NSPR
-
PPSPraemium Limited
PPS
-
ADGCFAdvance Lithium Corp.
ADGCF
-
2427
-
CIBEY
-
RXRX
-
603606
-
MANAPPURAMManappuram Finance Limited
MANAPPURAM